These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 20686609)

  • 1. Comparative functional genomics analysis of NNK tobacco-carcinogen induced lung adenocarcinoma development in Gprc5a-knockout mice.
    Fujimoto J; Kadara H; Men T; van Pelt C; Lotan D; Lotan R
    PLoS One; 2010 Jul; 5(7):e11847. PubMed ID: 20686609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of Kras mutant lung adenocarcinoma in mice with knockout of the airway lineage-specific gene Gprc5a.
    Fujimoto J; Nunomura-Nakamura S; Liu Y; Lang W; McDowell T; Jakubek Y; Ezzeddine D; Kapere Ochieng J; Petersen J; Davies G; Fukuoka J; Wistuba II; Ehli E; Fowler J; Scheet P; Kadara H
    Int J Cancer; 2017 Oct; 141(8):1589-1599. PubMed ID: 28653505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of lung tumorigenesis in a Gprc5a Knockout mouse by chronic extrinsic airway inflammation.
    Barta P; Van Pelt C; Men T; Dickey BF; Lotan R; Moghaddam SJ
    Mol Cancer; 2012 Jan; 11():4. PubMed ID: 22239913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Gprc5a tumor suppressor loss of expression signature is conserved, prevalent, and associated with survival in human lung adenocarcinomas.
    Kadara H; Fujimoto J; Men T; Ye X; Lotan D; Lee JS; Lotan R
    Neoplasia; 2010 Jun; 12(6):499-505. PubMed ID: 20563252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of ferret as a human lung cancer model by injecting 4-(Nmethyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone (NNK).
    Aizawa K; Liu C; Veeramachaneni S; Hu KQ; Smith DE; Wang XD
    Lung Cancer; 2013 Dec; 82(3):390-6. PubMed ID: 24396883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of the retinoic acid-inducible Gprc5a as a new lung tumor suppressor gene.
    Tao Q; Fujimoto J; Men T; Ye X; Deng J; Lacroix L; Clifford JL; Mao L; Van Pelt CS; Lee JJ; Lotan D; Lotan R
    J Natl Cancer Inst; 2007 Nov; 99(22):1668-82. PubMed ID: 18000218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-Wide Gene Expression Changes in the Normal-Appearing Airway during the Evolution of Smoking-Associated Lung Adenocarcinoma.
    Kantrowitz J; Sinjab A; Xu L; McDowell TL; Sivakumar S; Lang W; Nunomura-Nakamura S; Fukuoka J; Nemer G; Darwiche N; Chami H; Tfayli A; Wistuba II; Scheet P; Fujimoto J; Spira AE; Kadara H
    Cancer Prev Res (Phila); 2018 Apr; 11(4):237-248. PubMed ID: 29382653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Array CGH analysis reveals chromosomal aberrations in mouse lung adenocarcinomas induced by the human lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone.
    Herzog CR; Desai D; Amin S
    Biochem Biophys Res Commun; 2006 Mar; 341(3):856-63. PubMed ID: 16455056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) induces cell proliferation in normal human bronchial epithelial cells through NFkappaB activation and cyclin D1 up-regulation.
    Ho YS; Chen CH; Wang YJ; Pestell RG; Albanese C; Chen RJ; Chang MC; Jeng JH; Lin SY; Liang YC; Tseng H; Lee WS; Lin JK; Chu JS; Chen LC; Lee CH; Tso WL; Lai YC; Wu CH
    Toxicol Appl Pharmacol; 2005 Jun; 205(2):133-48. PubMed ID: 15893541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted disruption of the galectin-3 gene results in decreased susceptibility to NNK-induced lung tumorigenesis: an oligonucleotide microarray study.
    Abdel-Aziz HO; Murai Y; Takasaki I; Tabuchi Y; Zheng HC; Nomoto K; Takahashi H; Tsuneyama K; Kato I; Hsu DK; Liu FT; Hiraga K; Takano Y
    J Cancer Res Clin Oncol; 2008 Jul; 134(7):777-88. PubMed ID: 18204863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of cytochrome P450 enzymes critical for lung tumorigenesis by the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK): insights from a novel Cyp2abfgs-null mouse.
    Li L; Megaraj V; Wei Y; Ding X
    Carcinogenesis; 2014 Nov; 35(11):2584-91. PubMed ID: 25173884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of microRNAs in early-stage neoplastic transformation in the lungs of F344 rats chronically treated with the tobacco carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone.
    Kalscheuer S; Zhang X; Zeng Y; Upadhyaya P
    Carcinogenesis; 2008 Dec; 29(12):2394-9. PubMed ID: 18780894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. K-ras mutations in lung tumors from A/J and A/J x TSG-p53 F1 mice treated with 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and phenethyl isothiocyanate.
    Matzinger SA; Crist KA; Stoner GD; Anderson MW; Pereira MA; Steele VE; Kelloff GJ; Lubet RA; You M
    Carcinogenesis; 1995 Oct; 16(10):2487-92. PubMed ID: 7586156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of Lung Tumors and Mutational Analysis in FVB/N Mice Treated with the Tobacco Carcinogen 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanone.
    Rothenberger NJ; Stabile LP
    Methods Mol Biol; 2020; 2102():149-160. PubMed ID: 31989553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the transplacental tumorigenicity of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in mice.
    Anderson LM; Hecht SS; Dixon DE; Dove LF; Kovatch RM; Amin S; Hoffmann D; Rice JM
    Cancer Res; 1989 Jul; 49(14):3770-5. PubMed ID: 2736518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant promoter hypermethylation of the death-associated protein kinase gene is early and frequent in murine lung tumors induced by cigarette smoke and tobacco carcinogens.
    Pulling LC; Vuillemenot BR; Hutt JA; Devereux TR; Belinsky SA
    Cancer Res; 2004 Jun; 64(11):3844-8. PubMed ID: 15172992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumorigenicity and metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol enantiomers and metabolites in the A/J mouse.
    Upadhyaya P; Kenney PM; Hochalter JB; Wang M; Hecht SS
    Carcinogenesis; 1999 Aug; 20(8):1577-82. PubMed ID: 10426810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early and delayed intervention with rapamycin prevents NNK-induced lung adenocarcinoma in A/J mice.
    Patlolla JM; Kopelovich L; Qian L; Zhang Y; Kumar G; Madka V; Mohammed A; Biddick L; Sadeghi M; Lightfoot S; Rao CV
    Oncol Rep; 2015 Dec; 34(6):2925-34. PubMed ID: 26397133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of cell cycle proteins in 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced mouse lung tumors.
    Sabourin CL; Wang QS; Ralston SL; Evans J; Coate J; Herzog CR; Jones SL; Weghorst CM; Kelloff GJ; Lubet RA; You M; Stoner GD
    Exp Lung Res; 1998; 24(4):499-521. PubMed ID: 9659580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergism between 2,3,7,8-tetrachlorodibenzo-p-dioxin and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone on lung tumor incidence in mice.
    Wang YJ; Chang H; Kuo YC; Wang CK; Siao SH; Chang LW; Lin P
    J Hazard Mater; 2011 Feb; 186(1):869-75. PubMed ID: 21167638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.